SCHEMBL3074455

SCHEMBL3074455

NC(=O)c1nc(-c2cccs2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
HSD17B10 Q99714 4/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
MEN1 O00255 12/20 0.54
KMT2A Q03164 12/20 0.54
MAPT P10636 9/20 0.54
KDM4E B2RXH2 8/20 0.54
HPGD P15428 5/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
RAB9A P51151 4/20 0.54
TDP1 Q9NUW8 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
CASP3 P42574 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3739529 0.85 MEN1 (0.56) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL13078243 0.83 KDM4E (0.61) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL13044102 0.80 KDM4E (0.54) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL5761572 0.76 ALDH1A1 (0.55) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL3088513 0.76 MAP2K3 (0.50) NPC1CYP3A4CYP2D6CYP2C9KMT2A
SCHEMBL168593 0.76 ALDH1A1 (0.56) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL30882415 0.75 MAPT (0.56) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL3074458 0.74 HSD17B10 (1.00) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL2932828 0.73 KDM4E (0.61) NPC1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL4367503 0.72 SMN1; SMN2 (0.55) NPC1HSD17B10CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276453-A1 Anti-Cytokine Heterocyclic Compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-12-07 US claimed
US-7790712-B2 Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICAL, INC. (US) 2010-09-07 US disclosed
US-20060276453-A1 Anti-Cytokine Heterocyclic Compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276453-A1 Anti-Cytokine Heterocyclic Compounds MAPKAPK2, MAP4K2, MAP3K2 NPC1 4214/4885HSD17B10 2791/4885CYP1A2 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.